BioSpace News Archive

Galmed Pharmaceuticals Ltd. announced that it will present new data at The Liver Meeting®, the annual meeting of the American Association for the Study of Liver Diseases in Boston, November 8-12, 2019.

Pendulum Therapeutics announced that the California Life Sciences Association has awarded it the 2019 Pantheon DiNA™ Award for Rising Star.

Psychemedics Corporation (NASDAQ:PMD) today issued a response to a Massachusetts Supreme Judicial Court ruling in the case of Boston Police Department v. The Massachusetts Civil Service Commission, which dealt with the Boston Police Department’s 2012 decision not to hire an applicant after the applicant failed a Psychemedics Hair Test

Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today presented data for MRT5005, an inhaled mRNA therapeutic, at the 33rd Annual North American Cystic Fibrosis Conference (NACFC) taking place in Nashville, Tennessee from October 31 to November 2, 2019.

Seneca Biopharma, Inc., (Nasdaq: CUR), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, will begin trading on the Nasdaq Capital Market under the ticker symbol, NASDAQ: SNCA beginning on November 1, 2019.

Development of novel therapies will drive market growth in North America

A new study released today at the 89th Annual Meeting of the American Thyroid Association (ATA) calls into question the pharmacy practice of creating custom made thyroid hormone formulations for individual patients.

TAI Diagnostics Announces New Publication in The Journal of Heart and Lung Transplantation

Financial position strengthened with the issuance of a €20m mandatory convertible bond

Swedish Orphan Biovitrum AB announces its results for the third quarter 2019.